Percutaneous Repair of Paravalvular Leaks After TAVR: The Challenge of Identifying Eligible Subjects

Courtesy of Dr. Carlos Fava.

Percutaneous Repair of Paravalvular Leaks After TAVRThis study enrolled 72 patients who underwent transcatheter aortic valve replacement with an Edwards Sapiens valve, and then experienced a leak of at least moderate severity.

 

Fifteen of them underwent a percutaneous leak repair after identification of the leak mostly through the presence of symptoms.

 

Both groups were similar. Patients who underwent percutaneous repair were younger. Plugs were used in the repair, and no patient experienced hemolytic anemia.

 

The procedure was successful in 13 patients. In 2 of them, crossing of the leak was impossible to achieve. One patient who continued experiencing symptoms required a new intervention.

 

At 20 months of follow-up, there was 1 (13.8%) death in the group of patients who underwent a leak repair and 24 (42%) deaths in the control group. Leak repairs benefited patients, who experienced improvement in symptom status, reduction in subsequent hospitalizations, and reduction in B-type natriuretic peptide levels.

 

Conclusion

Transcatheter repair of paravalvular leaks after TAVR can be safe and effective in a selected patient group and may lead to reductions in hospitalizations, and improvement in symptoms and long-term survival.

 

Editorial Comment

Paravalvular leaks with current technology occur in 13%-15% of cases and are one of the technological challenges to be worked out in the future.

 

In these cases, identifying patients eligible for this procedure is of the utmost importance, since leaks can be repaired safely and effectively, improving quality of life and long-term survival.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Title: Outcome of Paravalvular Leak Repair After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prothesis.

 Reference: Abhijeet Dhoble, et al. Catheterization and Cardiovascular Interventions 2017;89:462-468.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...

TAVI and Hypertrophic Cardiomyopathy: An Increasingly Common Association

Stenosis is a common disease affecting 5% of the elderly population. It is associated with hospitalizations, poor quality of life, and mortality.  The association between...

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...